The headline result was effectively in line, not a clear beat. Adjusted diluted EPS of $0.59 matched the higher published consensus estimate and was one cent above another $0.58 reference, but revenue of $3.441 billion came in about $19 million below the published $3.46 billion expectation. That leaves little room to call the quarter better than the market had expected, particularly because the EPS comparison uses GXO's adjusted measure rather than GAAP EPS of $0.22. (Adjusted EPS reconciliation; Income Statement)
| Q2 2026 metric | Reported | Q2 2025 | Standing expectation / comparison |
|---|---|---|---|
| Revenue | $3.441B | $3.299B | Published consensus: ~$3.46B; modest shortfall (Income Statement) |
| Organic revenue growth | 3.4% | — | Below reported revenue growth of 4.3% after a $29M FX headwind (Organic revenue table) |
| Adjusted diluted EPS | $0.59 | $0.57 | Published consensus: ~$0.58-$0.59; essentially met (Adjusted EPS reconciliation) |
| Adjusted EBITDA | $219M | $212M | +3%; margin unchanged at 6.4% (Adjusted EBITDA reconciliation) |
| Operating income | $77M | $89M | Down 13%; margin fell to 2.2% from 2.7% (Income Statement; Adjusted EBITDA reconciliation) |
| Free cash flow | $12M | $(43)M | Improved sharply, though first-half FCF remained negative $19M (Free cash flow table) |
Growth continued, but profitability did not show the operating leverage a stronger result would need. Revenue grew 4.3% and every reported region contributed to organic growth, but adjusted EBITDA increased only 3% and its margin stayed flat at 6.4%. More importantly, adjusted EBITA margin slipped to 3.8% from 4.0%, while GAAP operating margin declined by 50 basis points. In plain terms: GXO added sales without translating them into better quarter-on-quarter profit efficiency. (Geographic revenue table; Adjusted EBITDA reconciliation; Adjusted EBITA reconciliation)
Commercial momentum is the constructive offset, but it is future pipeline rather than current-quarter upside. New business wins rose 34% year over year to about $410 million, and management said more than $1 billion of incremental 2026 revenue was already secured. That supports the growth narrative, yet it does not change the near-term read: current revenue landed a little light versus consensus and margins were flat to down. (CEO commentary)
Cash generation improved materially, while leverage remains meaningful. Second-quarter operating cash flow rose to $76 million from $3 million and free cash flow turned positive, a real improvement from last year. Still, working-capital use left first-half free cash flow at negative $19 million; net debt was $2.435 billion and net leverage was 2.6x trailing adjusted EBITDA. (Cash Flow statement; Free cash flow table; Net debt and net leverage tables)
The key missing catalyst is a disclosed guidance change. GXO had previously guided to 4%-5% organic revenue growth, $935-$975 million of adjusted EBITDA, $2.90-$3.20 of adjusted diluted EPS, and 30%-40% free-cash-flow conversion for 2026. The furnished Q2 materials reference full-year guidance but do not provide revised ranges, so this filing does not substantiate an upgrade. With earnings roughly meeting expectations and revenue slightly short, the overall read is mixed rather than positive. (Forward-looking statements; prior 2026 guidance)
Read the original 8-K on SEC EDGAR ↗